Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.
What’s New in Specialty Management for Moderate to Severe Atopic Dermatitis?
Dr. Peter Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at the Northwestern University Feinberg School of Medicine. He received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children's Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and has spoken nationally and internationally about atopic dermatitis, as well as alternative medicine.
Dr. Alexis Tracy is a combined allergy and dermatology research fellow at Rady Children's Hospital in San Diego, California. Coming from a military family, she has lived all over the world and has completed medical school at UT Health Science Center at San Antonio and then went on to train as a preliminary intern with the internal medicine program at the University of California, San Diego. She is excited to apply to dermatology residency in 2021!
Dr. Bob Geng is an Assistant Professor of Medicine and Pediatrics at the University of California, San Diego School of Medicine. He is also affiliated with Rady Children's Hospital. Dr. Geng sees both Pediatric as well as Adult patients for Allergic and Immunologic disorders. He is currently the Allergy Director of the Multidisciplinary Atopic Dermatitis Program at Rady, and also serves as the Co-Director of the Allergy Asthma Foundation-UCSD Severe Asthma Program at Rady.
Dr. Geng received his Bachelor of Science as well as Masters of Arts from Georgetown University. He received his Doctorate in Medicine from Washington University in St. Louis School of Medicine. He then went on to complete a Residency in Internal Medicine at Washington University in St. Louis/Barnes-Jewish Hospital. Following that, he went on to pursue a Fellowship in Allergy & Immunology at University of California, Los Angeles. He also completed a Fellowship in Clinical Pharmacology at University of California, Los Angeles. Upon completion of training, he was recruited by University of California, San Diego to serve as clinical faculty. He spends half of his time in clinical medicine, and the rest of his time in academic pursuits such as teaching and research. His focus of research has been on the use of Targeted Precision Medicine therapies on the treatment of Allergic and Immunologic disorders. He is the Principal Investigator on numerous studies and collaborate with an extensive team of basic scientists on Translational Research pertaining to Allergy/Immunology.
Dr. Gil Yosipovitch is a Professor of Dermatology at the Miller School of Medicine at University of Miami, and Director of the Miami Itch Center. The Itch Center focuses on diagnosing and treating chronic itch of different types, conducting research on neuroanatomy and neurophysiology of itch in humans and animal models and developing anti pruritic drugs that target the neural system.
Dr. Lawrence Eichenfield is chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego, as well as vice chair of the Department of Dermatology and a professor of dermatology and pediatrics at UC San Diego School of Medicine.
Dr. Eichenfield earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children's Hospital of Philadelphia, and completed dermatology training at the hospital of the University of Pennsylvania. He is board certified in pediatrics, dermatology and pediatric dermatology.
Dr. Peter Lio is a Clinical Assistant Professor of Dermatology and Pediatrics at the Northwestern University Feinberg School of Medicine. He received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children's Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and has spoken nationally and internationally about atopic dermatitis, as well as alternative medicine.
Dr. Vivian Shi, MD is an Associate Professor of the Department of Dermatology at the University of Arkansas for Medical Sciences (UAMS), where she directs the Eczema Clinic and Hidradenitis Suppurativa Clinic.
Dr. Shi received her undergraduate degree in physiological sciences from UCLA, and
subsequently spent a year performing research on gene regulation in pathogenic bacteria in the department of microbiology at UCLA. She learned her medical degree from the University of Illinois at Chicago. During that time, she also completed a fellowship in the Skin Immunology Laboratory. She was an integral part of the team characterizing the pathophysiology of atopic dermatitis. She then completed her internship in Internal Medicine at the University of Chicago – NorthShore Health System, followed by a dermatology residency at the University of California, Davis, where she also served as chief resident.
Dr. Shi’s research and clinical interests are in complex inflammatory skin conditions (such atopic dermatitis, hidradenitis suppurativa, and psoriasis), skin barrier repair, transepidermal drug delivery, and integrative dermatology. She has served as the principal investigator for numerous industry-sponsored and investigator-initiated clinical and translational studies. She has published over 150 peer-reviewed articles and is the editor for two reference dermatology textbooks on atopic dermatitis and hidradenitis suppurativa. She is on the Board of Directors for the Hidradenitis Suppurativa Foundation, advisory board of the National Eczema Association, and is a member of the International Eczema Council.